A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
ALK-Abelló A/S
ClinicalTrials.gov Identifier:
NCT00773240
First received: October 15, 2008
Last updated: August 27, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
No publications provided by ALK-Abelló A/S

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):